Thomas Suter

Statistics

Publications

Citations

11K

H-Index

Active since

1987

Affiliations

Swiss Federal Laboratories for Materials Science and Technology(Current)

University of Utah

ETH Zurich

École Polytechnique Fédérale de Lausanne

University Hospital of Bern

Thomas Suter is an author at Swiss Federal Laboratories for Materials Science and Technology specializing in materials science, natural sciences, and materials engineering.

ORCID

Publications per year

1987–2024

Publications

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

José Luis Zamorano, Patrizio Lancellotti, Daniel Muñoz et al. · European Heart Journal · 2016 · 2.5K citations · Full text

Medicine, Oncology, Toxicology +17

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

Gϋnter von Minckwitz, Marion Procter, Evandro de Azambuja et al. · New England Journal of Medicine · 2017 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +17

BNP-Guided vs Symptom-Guided Heart Failure Therapy

Matthias Pfisterer, Peter Buser, Hans Rickli et al. · JAMA · 2009 · 644 citations

Medicine, Cardiology, Internal Medicine +15

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

John R. Teerlink, Rafael Díaz, G. Michael Felker et al. · New England Journal of Medicine · 2020 · 644 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Trastuzumab-Associated Cardiac Adverse Effects in the Herceptin Adjuvant Trial

Thomas Suter, Marion Procter, Dirk J. van Veldhuisen et al. · Journal of Clinical Oncology · 2007 · 565 citations · Full text

Medicine, Cardiology, Oncology +17

1–5 of 66